The Scientist

» pharma and developmental biology

Most Recent

image: Stems Cells Ushered into Embryonic Development

Stems Cells Ushered into Embryonic Development

By | November 7, 2014

The right mix of mouse embryonic stem cells in a dish will start forming early embryonic patterns, according to two studies.

0 Comments

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: Precisely Placed

Precisely Placed

By | September 1, 2014

Vein patterns in the wings of developing fruit flies never vary by more than the width of a single cell.

3 Comments

image: Roche Buys Biotech for $8.3B

Roche Buys Biotech for $8.3B

By | August 27, 2014

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

0 Comments

image: Crayfish Blood Cells Make New Neurons

Crayfish Blood Cells Make New Neurons

By | August 13, 2014

Hemocytes can form neurons in adult crayfish, a study shows.

0 Comments

image: Roche Set to Buy RNAi Firm

Roche Set to Buy RNAi Firm

By | August 6, 2014

The Swiss pharmaceutical giant will reportedly pay $450 million for a Danish biotech company that develops drugs that silence microRNAs.

2 Comments

image: Arrested Development Makes for Long-Lived Worms

Arrested Development Makes for Long-Lived Worms

By | June 23, 2014

Starvation suspends cellular activity in C. elegans larvae and extends their lifespan. 

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Merck Snaps Up Biotech for $3.85B

Merck Snaps Up Biotech for $3.85B

By | June 10, 2014

The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.

0 Comments

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech